Recent Updates
Recently added Catalysts
ATHE Positive Sentiment Score: 75/100

Appendix 2A - Application for quotation of securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Tuesday

Key Takeaway: Alterity Therapeutics Limited has announced its application for the quotation of a new class of securities on the ASX, with an exercise price of $0.028, set to expire on February 26, 2027. A total of 1,222,300,911 options are involved in this issuance, reflecting the company’s strategy to raise additional working capital. The announcement includes details pertaining to the quoted and issued capital following this quotation. The company's registered number is ABN 37080699065, and the application suggests proactive steps toward funding its operational needs.

Market Sentiment Analysis

POSITIVE FACTORS

  • Alterity Therapeutics is applying for quotation of new securities which may enhance its market presence.
  • The securities issuance aims to raise additional working capital, which could support development efforts.

Full Press Release Details

ALTERITY THERAPEUTICS LIMITED
Date of this announcement
Tuesday April 22, 2025
+securities to be quoted are:
Please refer to the response to Q2.3d for further information
about the type of securities to be quoted and the circumstances of the issue.
Total number of +securities to be quoted
ASX + security code Security description Number of +securities to be quoted Issue date
New class - code to be confirmed Options with exercise price of $0.028, expiring 26 February 2027 1,222,300,911 23/04/2025
Refer to next page for full details of the announcement
Part 1 - Entity and announcement details
ALTERITY THERAPEUTICS
We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX
1.2 Registered number type Registration number
ABN 37080699065
Date of this announcement
Part 2 - Type of Issue
+securities to be quoted are:
Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.
of +securities to be quoted is:
New +securities in a class that is not yet quoted on ASX ("new class")
+securities been offered under a +disclosure document or +PDS?
of +disclosure document or +PDS?
provide any further information needed to understand the circumstances in which you are applying to have these +securities quoted on
ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B
Part 3C - number and type of +securities to be quoted (new class) where issue has not previously been notified to ASX in an Appendix 3B
ASX +security code +Security description
New class - code to be confirmed Options with exercise price of $0.028, expiring 26 February 2027
+Security type ISIN code
Options
Will all the +securities issued in this class rank
equally in all respects from the issue date?
+Security currency Exercise price Expiry date
AUD - Australian Dollar AUD 0.02800000 26/2/2027
Details of the type of +security that will be issued
if an option is exercised
ATH : ORDINARY FULLY PAID
Number of +securities that will be issued if an option is exercised
Please provide a URL link for a document lodged with ASX setting out the material
terms of the +securities to be quoted or provide the information by separate announcement.
Number of +securities to be quoted
Are the +securities being issued for a cash consideration?
describe the consideration being provided for the +securities
Please provide an estimate (in AUD) of the value of
the consideration being provided per +security for the
+securities to be quoted
Any other information the entity wishes to provide about the +securities to be quoted
The purpose(s) for which the entity is issuing the securities
To raise additional working capital
Part 4 - Issued capital following quotation
quotation of the +securities the subject of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix
2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
4.1 Quoted +securities
(total number of each +class of +securities quoted on ASX following the +quotation of the+securities subject of this application)
ASX +security code and description Total number of +securities on issue
ATH : ORDINARY FULLY PAID 9,127,370,686
ATHO : OPTION EXPIRING 31-AUG-2026 932,611,269
New class - code to be confirmed : Options with exercise price of $0.028, expiring 26 February 2027 1,222,300,911
+securities (total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description Total number of +securities on issue
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 14,250,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 11,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 35,000,000
ATHAAK : OPTION EXPIRING 30-DEC-2027 EX $0.01 170,000,000
ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105 8,000,000
ATHAB : OPTION EXPIRING 13-MAR-2029 EX US$0.0031 62,500,000
ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004 20,166,667
ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003 120,000,000
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 91,392,720
Part 5 - Other Listing Rule requirements
5.1 Are the +securities being issued under an exception
in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1?
5.2 Has the entity obtained, or is it obtaining, +security holder approval for the issue under listing rule 7.1?
5.2a Date of meeting or proposed meeting to approve the issue under listing rule 7.1

Frequently Asked Questions

What type of securities is Alterity Therapeutics issuing?

Alterity Therapeutics is issuing options with an exercise price of $0.028.

When do the new options expire?

The new options will expire on February 26, 2027.

What is the purpose of issuing these securities?

The securities are being issued to raise additional working capital.

How many new options are being quoted?

A total of 1,222,300,911 new options will be quoted.

What is the ASX security code for the new options?

The ASX security code for the new options is yet to be confirmed.

Last updated: Apr 22, 2025